X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (65) 65
index medicus (64) 64
somatostatinoma (34) 34
female (31) 31
tumors (25) 25
middle aged (24) 24
adult (22) 22
male (22) 22
pancreas (17) 17
pancreatic neoplasms - diagnosis (17) 17
pancreatic neoplasms - pathology (16) 16
somatostatinoma - pathology (16) 16
oncology (15) 15
pathology (15) 15
somatostatinoma - diagnosis (15) 15
insulinoma (14) 14
gastroenterology & hepatology (13) 13
neurofibromatosis (13) 13
surgery (13) 13
endocrinology & metabolism (12) 12
somatostatinoma - complications (12) 12
endocrine tumors (11) 11
gastrinoma (11) 11
pancreatic neoplasms - surgery (11) 11
somatostatinoma - genetics (11) 11
somatostatinoma - surgery (11) 11
zollinger-ellison-syndrome (11) 11
aged (10) 10
medicine & public health (10) 10
mutation (10) 10
neurofibromatosis 1 - complications (10) 10
pancreatic neoplasms - genetics (10) 10
diagnosis (9) 9
glucagonoma (9) 9
immunohistochemistry (9) 9
neuroendocrine tumors (9) 9
prognosis (9) 9
vipoma (9) 9
von-recklinghausens-disease (9) 9
abridged index medicus (8) 8
duodenal neoplasms - pathology (8) 8
neurofibromatosis 1 - pathology (8) 8
paraganglioma - genetics (8) 8
pheochromocytoma (8) 8
basic helix-loop-helix transcription factors - genetics (7) 7
duodenal somatostatinoma (7) 7
gene (7) 7
insulinoma - diagnosis (7) 7
islet-cell tumors (7) 7
neuroendocrine tumor (7) 7
pancreatic neoplasms - metabolism (7) 7
pancreatic neoplasms - therapy (7) 7
paraganglioma (7) 7
cancer (6) 6
carcinoid-tumors (6) 6
duodenal neoplasms - complications (6) 6
duodenal neoplasms - surgery (6) 6
gastrointestinal stromal tumors (6) 6
glucagonoma - diagnosis (6) 6
medicine, general & internal (6) 6
neuroendocrine tumors - diagnosis (6) 6
neuroendocrine tumors - genetics (6) 6
somatostatinoma - metabolism (6) 6
carcinoid (5) 5
carcinoid tumor - pathology (5) 5
expression (5) 5
gastrinoma - diagnosis (5) 5
gastrointestinal stromal tumors - pathology (5) 5
insulinoma - pathology (5) 5
neuroendocrine tumors - pathology (5) 5
neurofibromatosis type 1 (5) 5
pancreatic neoplasms - complications (5) 5
paraganglioma - pathology (5) 5
polycythemia (5) 5
polycythemia - genetics (5) 5
somatostatin - metabolism (5) 5
vipoma - diagnosis (5) 5
zollinger-ellison syndrome (5) 5
abdominal neoplasms - genetics (4) 4
adenoma, islet cell - pathology (4) 4
adolescent (4) 4
ampulla (4) 4
ampulla of vater - pathology (4) 4
animals (4) 4
carcinoma, neuroendocrine - pathology (4) 4
chromogranin-a (4) 4
clinical-features (4) 4
disease (4) 4
endocrine neoplasia type-1 (4) 4
gastrin (4) 4
gastrinoma - pathology (4) 4
gastrointestinal stromal tumors - complications (4) 4
glucagonoma - pathology (4) 4
incidence (4) 4
insulinoma - therapy (4) 4
localization (4) 4
mutations (4) 4
neuroendocrine tumors - therapy (4) 4
neurofibromatosis 1 - diagnosis (4) 4
pancreatic cancer (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 10, pp. 922 - 930
Journal Article
Blood, ISSN 0006-4971, 03/2013, Volume 121, Issue 13, pp. 2563 - 2566
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2161 - 2162
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 1 - 4
Paragangliomas (PGLs) belong to the most hereditary endocrine tumours. The existence of mutated HIF2A in these tumours, the role of oncometabolites on HIFs... 
Hypoxia-inducible factor | Paraganglioma | von Hippel-Lindau | Renal cell carcinoma | Krebs cycle | ANTAGONIST | PHEOCHROMOCYTOMA | ONCOLOGY | HYPOXIA | Sulfones - therapeutic use | Kidney Neoplasms - genetics | Humans | Carcinoma, Renal Cell - genetics | Tumor Microenvironment | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - metabolism | Molecular Targeted Therapy | Indans - therapeutic use | Tumor Hypoxia | Basic Helix-Loop-Helix Transcription Factors - metabolism | Drug Design | Carcinoma, Renal Cell - drug therapy | Paraganglioma - pathology | Basic Helix-Loop-Helix Transcription Factors - genetics | Signal Transduction | Carcinoma, Renal Cell - pathology | Paraganglioma - genetics | Paraganglioma - drug therapy | Basic Helix-Loop-Helix Transcription Factors - antagonists & inhibitors | Carcinoma, Renal Cell - metabolism | Paraganglioma - metabolism | Kidney Neoplasms - pathology | Mutation | Kidney Neoplasms - drug therapy | Endothelial growth factors | Tumors | Hypoxia-inducible factors | Medical research | Endocrine system | Brain tumors | Abnormalities | Disorders | Clinical trials | Retina | Antagonists | Signal transduction | Signaling | Metabolites | Pituitary | Kidney cancer | Hypoxia | Tumorigenesis | Clear cell-type renal cell carcinoma | Index Medicus | polycythemia | somatostatinoma | retinal abnormalities | pituitary tumor | hypoxia-inducible factor | hemangioblastoma | paraganglioma | leiomyosarcoma | renal cell carcinoma | gastrointestinal stromal tumor | metabolomics | leiomyoma | Warburg effect
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 03/2008, Volume 15, Issue 1, pp. 229 - 241
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/1982, Volume 79, Issue 15, pp. 4575 - 4579
Journal Article
Best Practice & Research Clinical Gastroenterology, ISSN 1521-6918, 2005, Volume 19, Issue 5, pp. 753 - 781
Endocrine pancreatic tumours (EPTs) are uncommon tumours occurring in approximately 1 in 100 000 of the population, representing 1–2% of all pancreatic... 
molecular genetics | localization | histopathology | medical treatment | biochemistry | endocrine pancreatic tumours | Biochemistry | Histopathology | Molecular genetics | Localization | Medical treatment | Endocrine pancreatic tumours | Immunohistochemistry | Glucagonoma - drug therapy | Pancreatic Neoplasms - epidemiology | Prognosis | Molecular Biology | Humans | Carcinoma, Neuroendocrine - epidemiology | Male | Incidence | Insulinoma - epidemiology | Pancreatic Neoplasms - drug therapy | Glucagonoma - epidemiology | Somatostatinoma - drug therapy | Somatostatinoma - pathology | Zollinger-Ellison Syndrome - epidemiology | Female | Zollinger-Ellison Syndrome - pathology | Gastrinoma - pathology | Glucagonoma - pathology | Somatostatinoma - epidemiology | Zollinger-Ellison Syndrome - drug therapy | Risk Assessment | Carcinoma, Neuroendocrine - drug therapy | Pancreatic Neoplasms - pathology | Insulinoma - drug therapy | Carcinoma, Neuroendocrine - genetics | Pancreatic Neoplasms - genetics | Survival Rate | Treatment Outcome | Gastrinoma - drug therapy | Carcinoma, Neuroendocrine - pathology | Insulinoma - pathology | Biopsy, Needle | Gastrinoma - epidemiology | Neoplasm Staging | NEUROENDOCRINE TUMORS | LONG-TERM SURVIVAL | CHROMOGRANIN-A | ZOLLINGER-ELLISON-SYNDROME | HIGH-DOSE TREATMENT | OBSTETRICS & GYNECOLOGY | NEURON-SPECIFIC ENOLASE | CARCINOID-TUMORS | ISLET-CELL TUMORS | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | MEDICAL ONCOLOGY GROUP | Biological response modifiers | Somatostatin | Tumors | Index Medicus | Carcinoma; Neuroendocrine/drug therapy/epidemiology/genetics/pathology | Comparative Study | Glucagonoma/drug therapy/epidemiology/pathology | Pancreatic Neoplasms/drug therapy/epidemiology/genetics/pathology | Gastrinoma/drug therapy/epidemiology/pathology | Zollinger-Ellison Syndrome/drug therapy/epidemiology/pathology | Insulinoma/drug therapy/epidemiology/pathology | Biopsy; Needle | Somatostatinoma/drug therapy/epidemiology/pathology
Journal Article